Chuanbin Mao Selected Research

Chuanbin Mao Research Topics

Disease

58	Neoplasms (Cancer) 01/2024 - 11/2009
13	Breast Neoplasms (Breast Cancer) 01/2024 - 10/2010
7	Bacterial Infections (Bacterial Infection) 03/2024 - 09/2014
6	Infections 03/2024 - 01/2015
5	Wounds and Injuries (Trauma) 02/2024 - 04/2018
5	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2015
5	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 12/2014
4	Inflammation (Inflammations) 01/2022 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 02/2020
3	Hypoxia (Hypoxemia) 12/2023 - 01/2020
2	Wound Infection (Wound Infections) 02/2024 - 04/2018
2	Melanoma (Melanoma, Malignant) 01/2024 - 02/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2017
2	Osteoarthritis 10/2021 - 12/2019
2	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 01/2011
2	Liver Neoplasms (Liver Cancer) 02/2020 - 01/2020
1	Periodontal Diseases (Periodontal Disease) 05/2024
1	Periodontitis 05/2024
1	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2024
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Intraoperative Complications 09/2022
1	COVID-19 07/2022
1	Stroke (Strokes) 05/2022
1	Cicatrix (Scar) 05/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Mouth Diseases (Mouth Disease) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Liver Diseases (Liver Disease) 11/2021

Drug/Important Bio-Agent (IBA)

20	Peptides (Polypeptides)IBA 10/2023 - 09/2010
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2010
8	Biocompatible Materials (Biomaterials)IBA 05/2024 - 01/2016
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
7	VaccinesIBA 01/2024 - 04/2016
6	HydrogelsIBA 05/2024 - 01/2019
6	GoldIBA 03/2019 - 08/2014
6	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 11/2009
5	LipidsIBA 10/2021 - 09/2014
5	LigandsIBA 02/2020 - 10/2010
5	Photosensitizing Agents (Photosensitizers)IBA 01/2018 - 09/2010
4	Drug CarriersIBA 01/2024 - 07/2014
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023 - 01/2013
4	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2017
4	BismuthIBA 01/2019 - 01/2018
3	Fibroins (Fibroin)IBA 02/2024 - 09/2022
3	AntigensIBA 09/2022 - 01/2016
3	PolymersIBA 10/2021 - 11/2019
3	AlloysIBA 01/2018 - 08/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2014
3	Liposomes (Liposome)IBA 01/2016 - 09/2010
2	Therapeutic UsesIBA 03/2024 - 03/2024
2	MetalsIBA 02/2024 - 01/2018
2	Metal-Organic FrameworksIBA 10/2023 - 10/2021
2	EnzymesIBA 11/2022 - 09/2014
2	Monoclonal AntibodiesIBA 11/2021 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 11/2016
2	CollagenIBA 11/2019 - 09/2019
2	polydopamineIBA 11/2019 - 09/2017
2	GelatinIBA 01/2019 - 09/2017
2	IntegrinsIBA 01/2019 - 08/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 09/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 08/2018 - 01/2017
2	TitaniumIBA 01/2017 - 09/2014
2	Durapatite (Hydroxylapatite)IBA 11/2016 - 01/2016
2	MineralsIBA 11/2016 - 08/2015
2	IonsIBA 11/2016 - 08/2015
2	AntibodiesIBA 04/2016 - 01/2011
2	Aspartic Acid ProteasesIBA 04/2016 - 01/2015
2	Protamines (Protamine Sulfate)FDA Link 01/2016 - 09/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2024
1	Cancer VaccinesIBA 01/2024
1	AluminumIBA 01/2024
1	RNA Splicing FactorsIBA 12/2023
1	Neutralizing AntibodiesIBA 07/2022
1	Antiviral Agents (Antivirals)IBA 07/2022
1	Nucleic Acid-Based VaccinesIBA 07/2022
1	Ferritins (Ferritin)IBA 01/2022
1	AlbuminsIBA 01/2022
1	Silk FDA Link 01/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	baysilon (polydimethylsiloxane)IBA 01/2022
1	Glycocholic AcidIBA 11/2021
1	lubricinIBA 10/2021
1	Hyaluronic Acid (Hyaluronan)IBA 10/2021

Therapy/Procedure

38	Therapeutics 05/2024 - 09/2010
7	Precision Medicine 01/2022 - 01/2017
6	Drug Therapy (Chemotherapy) 10/2023 - 01/2016
5	Injections 05/2024 - 10/2021
5	Photochemotherapy (Photodynamic Therapy) 10/2019 - 01/2013
3	Photothermal Therapy 03/2019 - 01/2019
2	Immunotherapy 09/2022 - 12/2021
2	Microspheres (Microsphere) 09/2022 - 06/2017
1	Intraperitoneal Injections 03/2024
1	Intravenous Injections 01/2022
1	Intranasal Administration 01/2022
1	Intra-Articular Injections 10/2021